These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The clinical utility of JC virus antibody index measurements in the context of progressive multifocal leukoencephalopathy.
    Author: Reuwer AQ, Heron M, van der Dussen D, Schneider-Hohendorf T, Murk JL.
    Journal: Acta Neurol Scand; 2017 Nov; 136 Suppl 201():37-44. PubMed ID: 29068484.
    Abstract:
    In natalizumab-treated patients without previous immunosuppressive treatment, the JCV antibody index is used to stratify PML risk. A high index value indicates that the risk to develop PML is significantly elevated, although probably about 99% of patients with this index value will not develop PML. This minireview aimed to provide an overview of the basic virology and immunology relevant to understanding JCV infections in MS patients, with a focus on what is presently known about antibodies to JCV and how they could be of use to predict and diagnose PML.
    [Abstract] [Full Text] [Related] [New Search]